Biology of anti-TNF agents in immune-mediated inflammatory diseases: therapeutic implications
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biology of anti-TNF agents in immune-mediated inflammatory diseases: therapeutic implications
Authors
Keywords
-
Journal
Immunotherapy
Volume 8, Issue 12, Pages 1427-1436
Publisher
Future Medicine Ltd
Online
2016-10-14
DOI
10.2217/imt-2016-0067
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Tumour Necrosis Factor in the Pathogenesis of Immune-Mediated Diseases
- (2017) C. Blandizzi et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Anti-TNF Agents as Therapeutic Choice in Immune-Mediated Inflammatory Diseases: Focus on Adalimumab
- (2017) A. Armuzzi et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Reporting of potential immunogenicity with biologic drugs: clarity and accuracy required
- (2016) Robert J Moots et al. ANNALS OF THE RHEUMATIC DISEASES
- Noncovalent PEGylation, An Innovative Subchapter in the Field of Protein Modification
- (2016) Christian Reichert et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
- (2016) Peter L. Turecek et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management
- (2015) N. S. Ding et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis
- (2015) David Ternant et al. CLINICAL PHARMACOKINETICS
- Immunogenicity of anti-TNF biologic agents in the treatment of rheumatoid arthritis
- (2015) Chi Chiu Mok et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Proteolytic Cleavage and Loss of Function of Biologic Agents That Neutralize Tumor Necrosis Factor in the Mucosa of Patients With Inflammatory Bowel Disease
- (2015) Paolo Biancheri et al. GASTROENTEROLOGY
- Cross-reactive and pre-existing antibodies to therapeutic antibodies—Effects on treatment and immunogenicity
- (2015) Karin A van Schie et al. mAbs
- Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions
- (2015) Céline Monnet et al. Frontiers in Immunology
- Tumour Necrosis Factor α Antagonists in the Treatment of Rheumatoid Arthritis: An Immunological Perspective
- (2014) Pier-Luigi Meroni et al. BIODRUGS
- Pegylation of Biological Molecules and Potential Benefits: Pharmacological Properties of Certolizumab Pegol
- (2014) Gianfranco Pasut BIODRUGS
- Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
- (2014) Johan J.F. Verhoef et al. DRUG DISCOVERY TODAY
- Dissection of the Neonatal Fc Receptor (FcRn)-Albumin Interface Using Mutagenesis and Anti-FcRn Albumin-blocking Antibodies
- (2014) Kine Marita Knudsen Sand et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor (FcRn) Binding
- (2014) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PEG — A versatile conjugating ligand for drugs and drug delivery systems
- (2014) Atul Kolate et al. JOURNAL OF CONTROLLED RELEASE
- Modeling approach to investigate the effect of neonatal Fc receptor binding affinity and anti-therapeutic antibody on the pharmacokinetic of humanized monoclonal anti-tumor necrosis factor-α IgG antibody in cynomolgus monkey
- (2013) Chee M. Ng et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
- (2013) Pauline A. van Schouwenburg et al. Nature Reviews Rheumatology
- The Immunogenicity of Polyethylene Glycol: Facts and Fiction
- (2013) Huub Schellekens et al. PHARMACEUTICAL RESEARCH
- PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins
- (2013) M. Schlapschy et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Antibodies to N-homocysteinylated albumin and haemoglobin in patients with rheumatoid arthritis: a potential new marker of disease severity
- (2013) A Nowakowska-Plaza et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- The role of Fc receptors and complement in autoimmunity
- (2012) Sidonia Mihai et al. AUTOIMMUNITY REVIEWS
- Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease
- (2012) Ingrid Ordás et al. Clinical Gastroenterology and Hepatology
- Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms
- (2012) I Ordás et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Drug Delivery Trends in Clinical Trials and Translational Medicine: Growth in Biologic Molecule Development and Impact on Rheumatoid Arthritis, Crohn's Disease, and Colitis
- (2012) Rodney J.Y. Ho et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Fc Gamma Receptor CD64 Modulates the Inhibitory Activity of Infliximab
- (2012) Kacper A. Wojtal et al. PLoS One
- Strategies for extended serum half-life of protein therapeutics
- (2011) Roland E Kontermann CURRENT OPINION IN BIOTECHNOLOGY
- Pharmacokinetics of Humanized Monoclonal Anti-Tumor Necrosis Factor- Antibody and Its Neonatal Fc Receptor Variants in Mice and Cynomolgus Monkeys
- (2010) R. Deng et al. DRUG METABOLISM AND DISPOSITION
- Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls
- (2010) Léia CR Silva et al. Immunotherapy
- Fc RIV deletion reveals its central role for IgG2a and IgG2b activity in vivo
- (2010) F. Nimmerjahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and safety of adalimumab in a patient with ankylosing spondylitis on peritoneal dialysis
- (2010) Senol Kobak RHEUMATOLOGY INTERNATIONAL
- Technology comparisons for anti-therapeutic antibody and neutralizing antibody assays in the context of an anti-TNF pharmacokinetic study
- (2009) Kelly M. Loyet et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab
- (2008) Hiroki Mitoma et al. ARTHRITIS AND RHEUMATISM
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Role of chaperones and FcγR in immunogenic death
- (2008) Madhav V Dhodapkar et al. CURRENT OPINION IN IMMUNOLOGY
- Ca2+-dependent Calmodulin Binding to FcRn Affects Immunoglobulin G Transport in the Transcytotic Pathway
- (2007) Bonny L. Dickinson et al. MOLECULAR BIOLOGY OF THE CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started